Gene Query: NDUFAB1

Dataset Description Geneva Score
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 41.07
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 30.39
KLF6-dependent transcription in renal cancer cells 24.31
Solid phase chemistry to covalently and reversibly capture thiolated RNA 20.69
SNHG5 siRNA knock down in HCT116 cells 20.53
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 18.0
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 17.45
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 17.45
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 16.79
Systematic discovery of endogenous human ribonucleoprotein complexes 15.74
Depicting early human development and germ cell origin with porcine embryos 15.7
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 15.68
Global analysis of enhancer targets: Mosaic-seq 15.48
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 15.45
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 15.2
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 15.0
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 14.99
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 14.99
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 14.9
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 14.58
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 14.57
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 14.56
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 14.56
Human embryonic stem cells in E8 and AKIT culture medium 14.34
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 14.34
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 14.33
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 14.24
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 14.14
Tracking distinct RNA populations using efficient and reversible covalent chemistry 14.08
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 13.83
Transcriptome sequencing of K-562 cells 13.8
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 13.77
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 13.77
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 13.69
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 13.57
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 13.57
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 13.26
AMPK signaling for naïve pluripotency [Hs] 13.09
AMPK signaling for naïve pluripotency 13.09
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 12.97
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 12.94
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 12.88
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 12.73
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 12.71
RNAseq of HEK293 cells after Chtop knockdown 12.59
Co-transcriptional loading of RNA export factors shapes the human transcriptome 12.59
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 12.37
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 12.37
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 12.23
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 12.2
Developmental stage specific chromosome architecture in human erythroid cells 12.14
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 12.14
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 12.12
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 12.07
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 11.91
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 11.82
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 11.75
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 11.71
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 11.64
RNA-seq of resting and activated CD4+ T cells +-JQ1 11.61
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 11.44
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 11.42
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 11.35
RNA-seq of IL-4 stimulated human keratinocytes 11.22
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 11.21
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 11.15
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 11.03
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 11.02
NRDE2 negatively regulates nuclear exosome functions 10.99
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 10.97
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 10.85
Regulation of protein translation during mitosis 10.69
Mitochondrial dsRNA triggers antiviral signalling in humans 10.42
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 10.41
Lysine benzoylation is a novel histone mark 10.37
Lysine benzoylation is a novel histone mark [RNA-seq] 10.37
IDH3a KO RNA-seq 10.33
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 10.27
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 10.24
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 10.24
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 10.23
Identification of transcription start sites for human A549 cell line using ReCappable-seq 10.23
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 10.15
Generating Patterned Kidney Organoids for Studying Development and Diseases 10.14
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 10.08
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 10.08
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 10.03
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 10.01
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 9.98
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 9.87
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 9.87
Electronic cigarettes 9.78
CROP-Seq in Primary Human T Cells 9.67
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 9.61
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 9.61
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 9.51
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 9.4
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 9.4
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 9.36
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 9.29
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 9.26
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 9.25
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 9.24
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 9.23
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 9.22
DART-seq: an antibody-free method for global m6A detection 9.19
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 9.18
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 9.13
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 9.13
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 9.08
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  8.99
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 8.99
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 8.96
Patient-derived luminal breast cancer xenografts with progestins 8.9
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 8.9
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 8.88
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 8.8
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 8.8
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 8.74
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 8.71
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 8.66
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 8.65
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 8.65
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 8.64
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 8.64
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 8.61
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 8.6
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 8.6
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 8.57
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 8.54
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 8.46
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 8.46
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.29
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 8.29
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 8.19
The landscape of alternative splicing in aggressive prostate cancers 8.19
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 8.16
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 8.15
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 8.11
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 8.09
U1 snRNP telescripting regulates size-function stratified human genome 8.07
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 8.05
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 7.94
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 7.92
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 7.88
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 7.81
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 7.79
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 7.77
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 7.74
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 7.73
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 7.73
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 7.7
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 7.7
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 7.7
Differential gene expression of human melanoma cells [RNA-seq] 7.66
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 7.66
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 7.62
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 7.55
Lipid degradation promotes prostate cancer cell survival 7.55
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 7.54
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 7.54
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 7.47
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 7.38
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 7.35
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 7.31
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 7.31
Transcriptome analysis of H9 hESC derived cerebral organoids 7.3
A549 cells and MSR-A549 cells 7.28
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 7.28
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 7.27
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 7.25
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 7.21
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 7.2
EP400 is required for Max and MCPyV mediated gene activation 7.15
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 7.13
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 7.13
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 7.13
The comparison of high-throughput single-cell RNA-seq methods 7.12
RNA sequencing of primary human platelets and in vitro cell lines 7.11
Gene expression profiling of leukemia cells following asparagine depletion 7.06
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 7.04
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 7.02
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 7.0
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 7.0
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 6.97
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 6.95
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 6.94
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 6.9
N6-methyladenine DNA Modification in Glioblastoma 6.89
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 6.89
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 6.88
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 6.87
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 6.81
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 6.81
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 6.81
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 6.8
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 6.75
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 6.74
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 6.74
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 6.73
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 6.72
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 6.66
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 6.66
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 6.6
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 6.6
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 6.57
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 6.56
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 6.56
Transcriptome analysis upon C6orf203 silencing 6.55
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 6.52
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 6.47
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 6.47
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 6.43
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 6.42
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 6.41
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 6.33
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 6.33
Effect of FGF13 depletion on the H460 cell line 6.31
Transcription control by the ENL YEATS domain in acute leukemia 6.3
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 6.3
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 6.26
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 6.25
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 6.24
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 6.23
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 6.21
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 6.21
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 6.21
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 6.16
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 6.13
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 6.11
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 6.07
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 6.05
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 6.04
Lineage specific differentiation is influenced by state of human pluripotency 6.01
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 6.01
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 6.0
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 5.92
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 5.92
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 5.91
RNA-sequencing of healthy human skeletal myocytes 5.91
Cajal bodies are linked to genome conformation [RNA-Seq] 5.88
Cajal bodies are linked to genome conformation 5.88
HEK293 Heat-shock experiment 5.88
Transcriptome landscape of HeLa response upon triamcinolone acetonide 5.82
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 5.81
Transcriptional profiling of microglia; current state of the art and future perspectives 5.81
The cohesin complex prevents Myc-induced replication stress 5.73
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 5.73
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 5.72
TOP2B disturbed the quality of human oocytes with advanced maternal age 5.71
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 5.7
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 5.65
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 5.64
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 5.63
MCF-7 as a model for functional analysis of breast cancer risk variants 5.63
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 5.54
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 5.46
Effect of ILF3 on translation during homeostasis and the antiviral response 5.44
Energy Metabolism during Anchorage-Independence 5.44
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 5.37
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 5.36
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 5.29
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 5.27
RNA-seq of naive and primed ES cells 5.26
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 5.21
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 5.19
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 5.18
Tracing Enhancer Networks using Epigenetic Traits (TENET) 5.16
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 5.14
RNA seq with AML (NB4) cells upon FTO inhibition 5.13
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 5.11
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 5.11
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 5.09
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 5.09
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 5.0
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 4.99
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 4.96
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 4.94
Genome-wide analysis of the Integrator complex 4.94
Genome-wide analysis of the Integrator complex (HTS) 4.94
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 4.92
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 4.92
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 4.9
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 4.9
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 4.87
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 4.83
O-glcnAc reprograms cellular energetics 4.82
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 4.81
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 4.77
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 4.76
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 4.76
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 4.71
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 4.71
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 4.71
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 4.71
Targeting MTHFD2 in Acute Myeloid Leukemia 4.68
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 4.65
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 4.65
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 4.64
The effect of insulin on mRNA transcription of human pluripotent stem cells 4.64
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.63
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 4.61
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 4.61
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 4.59
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 4.59
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 4.59
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 4.56
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 4.56
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 4.55
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 4.54
Gene expression regulated by CSA and CSB in neuroblastoma cell line 4.54
Epigenetic reprogramming of melanoma cells by vitamin C treatment 4.49
The MEF2B Regulatory Network - RNA-seq data 4.46
The MEF2B Regulatory Network 4.46
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 4.41
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 4.38
MARS Seq data from human cortical organoids 4.37
Single-cell analysis of human kidney organoids 4.37
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 4.35
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 4.35
An integrative analysis of non-coding regulatory DNA variations associated with autism 4.31
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 4.3
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 4.3
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 4.25
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 4.2
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 4.2
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 4.18
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 4.17
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 4.13
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 4.13
RNA-seq analysis upon ARID1B overexpression 4.1
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 4.09
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 4.08
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 4.05
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 4.03
Dilated cardiomyopathy vs Myocarditis 3.99
RNA editing in nascent RNA affects pre-mRNA splicing 3.97
Comprehensive comparative analysis of 5’ end RNA sequencing methods 3.9
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 3.87
Chromatin landscape of human visceral and subcutaneous adipocytes 3.86
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 3.85
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 3.85
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.84
RNA sequencing of mechanically strained NHEKs and control NHEKs 3.84
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 3.81
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 3.8
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 3.8
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 3.8
Effect of BMP inhibition or stimulation of primary human keratinocytes 3.79
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 3.79
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 3.76
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.66
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 3.64
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 3.64
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 3.61
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 3.59
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 3.59
Ribosome profiling upon inhibition of eIF4A 3.57
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.57
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.55
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.55
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 3.54
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.51
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 3.51
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 3.49
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 3.48
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 3.47
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 3.47
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 3.46
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 3.4
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 3.37
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 3.37
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 3.36
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 3.36
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.35
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 3.34
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 3.3
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.21
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.21
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 3.18
A20 regulates canonical wnt-signaling through an interaction with RIPK4 3.16
SLAM-seq for K562 endogenous mRNA decay 3.0
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.98
SF3B1 Degron knockdown RNA-seq 2.91
Effect of BB608 on Gene Expression in HNSCC Cell Line 2.86
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 2.86
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 2.86
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 2.86
Effect of PRDM11 depletion in U2932 cells 2.77
Comparative Analysis of Cas9 Activators Across Multiple Species 2.73
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 2.73
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 2.73
RNAseq of cell lines with knocked in ESR1 mutations 2.73
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 2.7
miRNAs affected by antagomiR-17 treatment 2.64
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 2.61
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 2.6
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 2.54
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 2.54
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 2.52
Identification of a LIF-responsive replication-competent human β cell 2.47
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.46
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 2.45
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 2.44
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 2.42
Single-cell analysis of adult human ovary using 10X genomics 2.41
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 2.39
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 2.38
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 2.33
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 2.32
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.31
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 2.29
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.28
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 2.26
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.25
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 2.25
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 2.17
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 2.07
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 2.06
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.99
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.9
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.87
RNA Sequencing of Human iPS derived Cardiomyocytes 1.86
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 1.86
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.82
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.82
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 1.8
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.79
K562 polyA RNA-Seq 1.75
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 1.67
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.67
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.66
Copper Regulation of HIF-1 Transcription Activity 1.66
An siRNA screen identifies CHD4 as a target for epigenetic therapy 1.65
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 1.65
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.65
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 1.65
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 1.57
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 1.52
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.52
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.48
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.48
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 1.46
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 1.42
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 1.4
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.36
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.32
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 1.27
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.26
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.24
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 1.24
RNA-seq data 1.23
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.22
Impact on erythroid progenitor type on erythroid differntiation 1.2
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.14
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.14
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.14
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.14
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 1.1
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 1.1
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.1
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.06
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 1.01
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 1.01
Global transcriptome analysis of WT versus HEB-/- hESCs 1.01
EGR1-controlled transcriptome of T HESCs 1.01
Modeling Human Cancer-induced Cachexia (Human) 0.98
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.98
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.93
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.93
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.92
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 0.88
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.86
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 0.84
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.84
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 0.81
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 0.81
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.72
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.72
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.69
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.66
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.65
Metastasis in triple-negative breast cancer 0.65
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 0.62
mRNA recovered upon RNF219 IP. [RNA-IP] 0.6
Dermal endothelial cells of type 2 diabetic patients 0.59
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 0.52
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.41
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.37
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.36
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.36
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.27
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.15
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.14
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.12
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.11
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.05
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.05
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.0
RNA-Seq and expression data from human adipose tissue 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation